Search results
Results From The WOW.Com Content Network
Symptoms of ADHD include inattention, hyperactivity and impulsivity — so people with this disorder might have trouble concentrating, staying organized, managing their time or controlling their ...
Some people only struggle with paying attention, some people can focus on tasks but are constantly fidgeting or dealing with excessive energy and some people exhibit both attention problems and ...
ADDitude magazine is a quarterly consumer publication about attention deficit hyperactivity disorder (ADHD or ADD) owned and operated by WebMD, LLC in New York, NY. It contains feature and service articles about ADD, ADHD and comorbid conditions including depression, anxiety, and learning disabilities like dyslexia.
Attention deficit hyperactivity disorder management options are evidence-based practices with established treatment efficacy for ADHD.Approaches that have been evaluated in the management of ADHD symptoms include FDA-approved pharmacologic treatment and other pharmaceutical agents, psychological or behavioral approaches, combined pharmacological and behavioral approaches, cognitive training ...
Litvintchouk, a married mother of four living in New York City, dropped out of high school and left the workforce — all things that research shows are more likely to happen to people with ADHD ...
[6] [13] [14] Supplemental history obtained from people close to the individual in different settings (e.g., parents, siblings, partners, teachers, coworkers, and employers) can help confirm a diagnosis. [12] ADHD is a highly genetically influenced condition, meaning it commonly runs in families.
ADHD has a negative impact on patient health-related quality of life that may be further exacerbated by, or may increase the risk of, other psychiatric conditions such as anxiety and depression. [232] Individuals with ADHD may also face misconceptions and stigma. [8] Individuals with ADHD are significantly overrepresented in prison populations.
The skeletal structure of norepinephrine The skeletal structure of dopamine. A norepinephrine–dopamine reuptake inhibitor (NDRI) is a drug used for the treatment of clinical depression, attention deficit hyperactivity disorder (ADHD), narcolepsy, and the management of Parkinson's disease.